Financials
- Market Capitalization 237.66 B
- Employee 32 K
- Founded 1980
- CEO Robert A. Bradway
- Website www.amgen.com
- Headquarter Delaware, United States
- FIGI BBG000BBS2Y0
- Industry Fabricants de Médicaments — Généralités
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
22.51
ratio cours/chiffre d'affaires
5.16
Dividende par action
2.52
Rendement du dividende (%)
2.74
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 31 | MRK Merck & Company, Inc. Common Stock | 150.97 USD | +0.69% | -1.71% | +16.85% | +76.72% | 372.47 B USD | ||
| 42 | NVS Novartis AG | 162.03 USD | +0.48% | +2.68% | +4.20% | +27.47% | 309.18 B USD | ||
| 80 | GILD Gilead Sciences, Inc. - Common Stock | 149.66 USD | -0.17% | +0.69% | +14.15% | +33.36% | 185.57 B USD | ||
| 99 | PFE Pfizer, Inc. Common Stock | 28.93 USD | +1.26% | +2.01% | +15.08% | +16.28% | 164.89 B USD |